Retrospective Study
Copyright ©The Author(s) 2017.
World J Hepatol. Jun 28, 2017; 9(18): 823-832
Published online Jun 28, 2017. doi: 10.4254/wjh.v9.i18.823
Table 1 Patient demographics
VariablesNo AKI (n = 58)Any grade of AKI (n = 58)P value
Patient characteristics
Age (yr)54 (18)56 (6)0.197
Female17 (29%)16 (28%)0.837
Weight (kg)75 (13)79 (15)0.163
Aetiology
Alcohol1314
Viral hepatitis2025
NASH27
Autoimmune167
Hepatocellular carcinoma1013
Other76
MELD score16 (7)16 (5.75)0.421
Hypertension8 (14%)9 (16%)0.733
Diabetes mellitus12 (21%)20 (34%)0.074
Pre-operative Haemoglobin (g/L)114 (20)107 (26)0.072
Baseline creatinine76 (39)75 (26)0.932
Table 2 Donor graft characteristics
VariablesNo AKI (n = 58)Any AKI (n = 58)P value
Graft characteristics
Donor age (yr)50 (14)47 (15)0.219
Organ status
DCD (%)7 (12%)10 (17%)0.454
Cold Ischaemic time (min)493 (133)493 (106)0.502
Table 3 Intraoperative variables
VariableNo AKI (n = 58)Any AKI (n = 58)P value
Intraoperative variables
Surgical technique
Piggyback33 (57%)22 (38%)0.041
Intraoperative blood products
RCC transfusion (units)1 (3)4 (5)0.001
FFP transfusion (units)0 (2)2 (6)0.001
Platelet transfusion (units)0 (1)0 (2)0.024
Cell salvage (mL)281 (550)764 (929)0.001
Noradrenaline infusion rate on arrival to ICU (μg/kg per minute)0.16 (0.10)0.18 (0.13)0.343
Table 4 Logistic regression analysis of variables associated with early acute kidney injury after liver transplantation
Univariate analysis
Multivariate model
VariablesOdds ratio (95%CI)P valueOdds ratio (95%CI)P value
Male gender1.088 (0.49-2.44)0.8370.430 (0.07-2.55)0.352
Weight1.020 (0.99-1.05)0.1641.026 (0.96-1.10)0.455
Age1.034 (0.999-1.07)0.0581.121 (1.02-1.23)0.019
Pre-transplant
Diabetes mellitus2.130 (0.92-4.92)0.0772.429 (0.48-12.41)0.286
Hypertension1.197 (0.43-3.36)0.7330.593 (0.04-8.04)0.694
Serum creatinine1.000 (0.99-1.01)0.9370.979 (0.96-1.002)0.078
MELD1.010 (0.97-1.05)0.6390.992 (0.91-1.08)0.845
Haemoglobin0.985 (0.97-1.002)0.0760.977 (0.93-1.02)0.311
Graft characteristics
DCD organ1.488 (0.52-4.23)0.4552.638 (0.30-23.12)0.381
Donor age0.984 (0.96-1.01)0.2180.964 (0.92-1.01)0.160
Cold ischaemic time1.001 (0.99-1.004)0.4981.000 (0.99-1.01)0.984
Peak serum AST < 24 h post OLT1.001 (1.00-1.001)0.0011.001 (1.00-1.001)0.020
Perioperative course
Caval replacement surgical technique2.160 (1.03-4.54)0.0423.289 (0.71-15-25)0.128
Noradrenaline infusion rate on ICU arrival4.830 (0.19-125.48)0.34347.468 (0.12-1836.27)0.204
RCC transfusion1.137 (1.03-1.26)0.0140.917 (0.64-1.32)0.645
FFP transfusion1.201 (1.07-1.35)0.0031.118 (0.84-1.48)0.440
Platelet transfusion1.499 (1.04-2.16)0.0301.948 (0.871-4.36)0.104
Cell salvage volume1.001 (1.00-1.001)0.0251.00 (0.999-1.002)0.808
Table 5 The effect of organ status and surgical technique on hepatic ischaemia reperfusion injury severity and the renal implications of increasing ischaemia reperfusion injury n (%)
Severity of HIRI
Mild (n = 35)Moderate (n = 68)Severe (n = 13)P value
DCD organs1/35 (2.9)11/68 (16.2)5/13 (38.5)0.007
Caval replacement16/35 (45.7)36/68 (52.9)9/13 (69.2)0.348
Incidence of AKI12/35 (34.3)34/68 (50.0)12/13 (92.3)0.002
Need for CVVHF5/35 (14.3)15/68 (22.1)8/13 (61.5)0.003
Development of CRF6/30 (20.0)19/53 (35.8)5/11 (45.5)0.195